You are here: Industry Insights > Heparin

News List

Optimvia, Ginkgo Bioworks to Manufacture Biosynthetic Heparin contractpharma
January 06, 2022
Optimvia to leverage Ginkgo's cell and enzyme engineering platform to improve the performance of Optimvia's biosynthetic heparin manufacturing technology.
Heparin may cut risk of severe disease and death in COVID-19 patients: Study expresspharma
July 16, 2021
The study showed that therapeutic heparin is beneficial in moderately ill hospitalised patients but not in severely ill ICU patients.
Novel spectroscopy technique could improve safety and quality of heparin europeanpharmaceuticalreview
May 19, 2021
Using time of flight secondary ion mass spectrometry (ToF-SIMS) enabled the detection of nanoscale quantities of glycosaminoglycan (GAG) contaminants in heparin.
Increased heparin dose reduces need for life support in hospitalised COVID-19 patients europeanpharmaceuticalreview
January 26, 2021
Interim data from 1,000 hospitalised patients with moderate COVID-19 symptoms shows that full doses of heparin can improve patient outcomes and could reduce ICU burden.
Lui Franciosi Reviewing the Use of Glycosaminoglycans (GAG) Molecules as Potential New Treatments for COVID-19 prnewswire
January 05, 2021
Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be reviewing the pharmacological feasibility of using specific glycosaminoglycans (GAGs) for the treatment of SARS-CoV-2, i.e., COVID-19.
US researchers say heparin may neutralise Covid-19 virus pharmaceutical-technology
July 17, 2020
Researchers at Rensselaer Polytechnic Institute in the US have said that the commonly available, US Food and Drug Administration (FDA)-approved drug heparin could effectively neutralise SARS-CoV-2, the virus that causes Covid-19.
The dark side of anticoagulants: will a new approach shed any light? pharmaceutical-technology
June 17, 2020
Anticoagulants are life-saving medicines, but they also raise the risk of patients haemorrhaging and bleeding to death.
Swine fever in China raises concern over heparin supply for US europeanpharmaceuticalreview
August 07, 2019
The US supply of heparin, an ingredient used in anticoagulant drugs and found in pigs, is under threat due to an outbreak of disease in Chinese herds.
A world reference and international leader in joint health en-cphi.cn
July 30, 2018
After CPhI China, En-cphi.cn interviewed Mr. Jaume Reguant, director of the Bioiberica Health Care Business Unit.